Uramaxin Gt label

Uramaxin Gt

Uramaxin Gt Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

WARNINGS: For external use only. Avoid contact with eyes, lips or mucous membranes.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

INDICATIONS AND USES: For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged, devitalized and ingrown nails.

History

There is currently no drug history available for this drug.

Other Information

DESCRIPTION:Uramaxin (45% Urea) GT is a keratolytic emollient, which is a gentle, yet potent, tissue softener for nails and/or skin. Each gram of Uramaxin (45% Urea) GT contains 45% Urea, camphor, edetate disodium, eucalyptus oil, hydroxyethyl cellulose, menthol, propylene glycol and purified water.

Urea is a diamide of carbonic acid with the following
chemical structure:

structure

Uramaxin Gt Manufacturers

  • Medimetriks Pharmaceuticals, Inc.
    Uramaxin Gt | Medimetriks Pharmaceuticals, Inc.
    No Recall

    Uramaxin Gt | Medimetriks Pharmaceuticals, Inc.

    Uramaxin Gt | Medimetriks Pharmaceuticals, Inc.

    DOSAGE AND ADMINISTRATION: DIRECTIONS FOR NAILS: Apply Uramaxin (45% Urea) GT to diseased or damaged nail tissue twice per day, or as directed by a physician.

    DIRECTIONS FOR SKIN: Apply Uramaxin (45% Urea) GT to affected area(s) twice per day, or as directed by a physician.